S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

SABS SAB Biotherapeutics Inc

3.71

-0.0842 (-2.22%)

Jan 02 2025 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

SAB Biotherapeutics (NASDAQ:SABS)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more SAB Biotherapeutics Charts.

SAB Biotherapeutics (NASDAQ:SABS)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more SAB Biotherapeutics Charts.

SAB Biotherapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 13 August 2024 (5 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Monday 12 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 8 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 31 July 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 31 July 2024 (5 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 17 July 2024 (6 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 17 July 2024 (6 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 17 July 2024 (6 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 17 July 2024 (6 months ago) • Edgar (US Regulatory)

SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company Updates
Monday 20 May 2024 (7 months ago) • GlobeNewswire Inc.

SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors
Monday 6 May 2024 (8 months ago) • GlobeNewswire Inc.

SAB Biotherapeutics Provides SAB-142 Trial Update
Tuesday 16 April 2024 (9 months ago) • GlobeNewswire Inc.

More SAB Biotherapeutics Inc News Articles

Accredited Solutions (PK)

Quantum eMotion (QB)

TPT Global Tech (CE)

Valiant Eagle (PK)

Fannie Mae (QB)

RespireRx Pharmaceuticals (CE)

Apple Rush (PK)

Anavex Life Sciences

Kraig Biocraft Laborator... (QB)

Moon Equity (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions